CASI Pharmaceuticals, Inc. (CASIF) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $16.0K | -92.8% |
| 2024 | $223.0K | +9.3% |
| 2023 | $204.0K | -96.4% |
| 2022 | $5.61M | -37.3% |
| 2021 | $8.95M | +496.7% |
| 2020 | $1.50M | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $16.0K | -92.8% |
| 2024 | $223.0K | +9.3% |
| 2023 | $204.0K | -96.4% |
| 2022 | $5.61M | -37.3% |
| 2021 | $8.95M | +496.7% |
| 2020 | $1.50M | — |